Sphingolipid metabolism in cancer signalling and therapy

Besim Ogretmen

doi:10.1038/nrc.2017.96

journal article Nov 17, 2017

Sphingolipid metabolism in cancer signalling and therapy

Besim Ogretmen

Nature Reviews Cancer Vol. 18 No. 1 pp. 33-50 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/nrc.2017.96

Topics

No keywords indexed for this article. Browse by subject →

References

176

[1]

Hannun, Y. A. & Obeid, L. M. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 9, 139–150 (2008). 10.1038/nrm2329

[2]

Hannun, Y. A. & Bell, R. M. Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. Science 235, 670–674 (1987). 10.1126/science.3101176

[3]

Tumor Necrosis Factor-α Activates the Sphingomyelin Signal Transduction Pathway in a Cell-Free System

Kenneth A. Dressler, Shalini Mathias, Richard N. Kolesnick

Science 1992 10.1126/science.1313189

[4]

Ogretmen, B. & Hannun, Y. A. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat. Rev. Cancer 4, 604–616 (2004). 10.1038/nrc1411

[5]

Cuvillier, O. et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381, 800–803 (1996). 10.1038/381800a0

[6]

Sphingosine-1-Phosphate as a Ligand for the G Protein-Coupled Receptor EDG-1

Menq-Jer Lee, James R. Van Brocklyn, Shobha Thangada et al.

Science 1998 10.1126/science.279.5356.1552

[7]

Sphingosine 1-phosphate and cancer

Nigel J. Pyne, Susan Pyne

Nature Reviews Cancer 2010 10.1038/nrc2875

[8]

Morad, S. A. et al. Ceramide-antiestrogen nanoliposomal combinations — novel impact of hormonal therapy in hormone-insensitive breast cancer. Mol. Cancer Ther. 11, 2352–2361 (2012). 10.1158/1535-7163.mct-12-0594

[9]

Venkataraman, K. et al. Upstream of growth and differentiation factor 1 (uog1), a mammalian homolog of the yeast longevity assurance gene 1 (LAG1), regulates N-stearoyl-sphinganine (C18-(dihydro)ceramide) synthesis in a fumonisin B1-independent manner in mammalian cells. J. Biol. Chem. 277, 35642–35649 (2002). This work provides biochemical details of how CERS proteins function in de novo ceramide synthesis. 10.1074/jbc.m205211200

[10]

Laviad, E. L., Kelly, S., Merrill, A. H. Jr & Futerman, A. H. Modulation of ceramide synthase activity via dimerization. J. Biol. Chem. 287, 21025–21033 (2012). 10.1074/jbc.m112.363580

[11]

Pewzner-Jung, Y., Ben-Dor, S. & Futerman, A. H. When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: Insights into the regulation of ceramide synthesis. J. Biol. Chem. 281, 25001–25005 (2006). 10.1074/jbc.r600010200

[12]

Kraveka, J. M. et al. Involvement of dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells. J. Biol. Chem. 282, 16718–16728 (2007). 10.1074/jbc.m700647200

[13]

Raichur, S. et al. CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. Cell Metab. 20, 687–695 (2014). 10.1016/j.cmet.2014.09.015

[14]

Jennemann, R. et al. Loss of ceramide synthase 3 causes lethal skin barrier disruption. Hum. Mol. Genet. 21, 586–608 (2012). 10.1093/hmg/ddr494

[15]

Ogretmen, B. et al. Biochemical mechanisms of the generation of endogenous long chain ceramide in response to exogenous short chain ceramide in the A549 human lung adenocarcinoma cell line. Role for endogenous ceramide in mediating the action of exogenous ceramide. J. Biol. Chem. 277, 12960–12969 (2002). This study demonstrates the mechanisms by which exogenous ceramide is utilized for endogenous ceramide generation via the salvage or recycling pathway. 10.1074/jbc.m110699200

[16]

Wijesinghe, D. S., Lamour, N. F., Gomez-Munoz, A. & Chalfant, C. E. Ceramide kinase and ceramide-1-phosphate. Methods Enzymol. 434, 265–292 (2007). 10.1016/s0076-6879(07)34015-9

[17]

Identification of a family of animal sphingomyelin synthases

Klazien Huitema, Joep van den Dikkenberg, Jos FHM Brouwers et al.

The EMBO Journal 2004 10.1038/sj.emboj.7600034

[18]

Watters, R. J. et al. Targeting glucosylceramide synthase synergizes with C6-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia. Leuk. Lymphoma 54, 1288–1296 (2013). 10.3109/10428194.2012.752485

[19]

D'Angelo, G. et al. Vesicular and non-vesicular transport feed distinct glycosylation pathways in the Golgi. Nature 501, 116–120 (2013). This manuscript describes mechanisms of ceramide trafficking by FAPP2 for glucosylceramide generation. 10.1038/nature12423

[20]

Simanshu, D. K. et al. Non-vesicular trafficking by a ceramide-1-phosphate transfer protein regulates eicosanoids. Nature 500, 463–467 (2013). This manuscript describes the mechanism of C1P trafficking to regulate inflammation. 10.1038/nature12332

[21]

Sphingolipid metabolites in inflammatory disease

Michael Maceyka, Sarah Spiegel

Nature 2014 10.1038/nature13475

[22]

Huang, W. C. et al. Sphingosine-1-phosphate phosphatase 2 promotes disruption of mucosal integrity, and contributes to ulcerative colitis in mice and humans. FASEB J. 30, 2945–2958 (2016). 10.1096/fj.201600394r

[23]

Zamora-Pineda, J., Kumar, A., Suh, J. H., Zhang, M. & Saba, J. D. Dendritic cell sphingosine-1-phosphate lyase regulates thymic egress. J. Exp. Med. 213, 2773–2791 (2016). 10.1084/jem.20160287

[24]

Sandhoff, K. Metabolic and cellular bases of sphingolipidoses. Biochem. Soc. Trans. 41, 562–568 (2013). 10.1042/bst20130083

[25]

Rosenbloom, B. E. et al. Gaucher disease and cancer incidence: a study from the Gaucher Registry. Blood 105, 4569–4572 (2005). 10.1182/blood-2004-12-4672

[26]

Han, G. et al. Identification of small subunits of mammalian serine palmitoyltransferase that confer distinct acyl-CoA substrate specificities. Proc. Natl Acad. Sci. USA 106, 8186–8191 (2009). 10.1073/pnas.0811269106

[27]

Bode, H. et al. HSAN1 mutations in serine palmitoyltransferase reveal a close structure-function-phenotype relationship. Hum. Mol. Genet. 25, 853–865 (2016). 10.1093/hmg/ddv611

[28]

Kramer, R. et al. Neurotoxic 1-deoxysphingolipids and paclitaxel-induced peripheral neuropathy. FASEB J. 29, 4461–4472 (2015). 10.1096/fj.15-272567

[29]

Orm family proteins mediate sphingolipid homeostasis

David K. Breslow, Sean R. Collins, Bernd Bodenmiller et al.

Nature 2010 10.1038/nature08787

[30]

Siow, D. L. & Wattenberg, B. W. Mammalian ORMDL proteins mediate the feedback response in ceramide biosynthesis. J. Biol. Chem. 287, 40198–40204 (2012). 10.1074/jbc.c112.404012

[31]

Meyers-Needham, M. et al. Concerted functions of HDAC1 and microRNA-574-5p repress alternatively spliced ceramide synthase 1 expression in human cancer cells. EMBO Mol. Med. 4, 78–92 (2012). 10.1002/emmm.201100189

[32]

Koybasi, S. et al. Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas. J. Biol. Chem. 279, 44311–44319 (2004). This study describes a selective role for CERS1-generated C18 ceramide in head and neck cancer cell death. 10.1074/jbc.m406920200

[33]

Thomas, R. J. et al. HPV/E7 induces chemotherapy-mediated tumor suppression by ceramide-dependent mitophagy. EMBO Mol. Med. 9, 1030–1051 (2017). 10.15252/emmm.201607088

[34]

Park, W. J. et al. Development of pheochromocytoma in ceramide synthase 2 null mice. Endocr. Relat. Cancer 22, 623–632 (2015). 10.1530/erc-15-0058

[35]

Fekry, B. et al. CerS6 is a novel transcriptional target of p53 protein activated by non-genotoxic stress. J. Biol. Chem. 291, 16586–16596 (2016). 10.1074/jbc.m116.716902

[36]

White-Gilbertson, S. et al. Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells. Oncogene 28, 1132–1141 (2009). 10.1038/onc.2008.468

[37]

Lee, H. et al. Mitochondrial ceramide-rich macrodomains functionalize Bax upon irradiation. PLoS ONE 6, e19783 (2011). 10.1371/journal.pone.0019783

[38]

Jensen, S. A. et al. Bcl2L13 is a ceramide synthase inhibitor in glioblastoma. Proc. Natl Acad. Sci. USA 111, 5682–5687 (2014). 10.1073/pnas.1316700111

[39]

Senkal, C. E., Ponnusamy, S., Bielawski, J., Hannun, Y. A. & Ogretmen, B. Antiapoptotic roles of ceramide-synthase-6-generated C16-ceramide via selective regulation of the ATF6/CHOP arm of ER-stress-response pathways. FASEB J. 24, 296–308 (2010). 10.1096/fj.09-135087

[40]

Suzuki, M. et al. Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells. J. Clin. Invest. 126, 254–265 (2016). 10.1172/jci79775

[41]

Senkal, C. E. et al. Alteration of ceramide synthase 6/C16-ceramide induces activating transcription factor 6-mediated endoplasmic reticulum (ER) stress and apoptosis via perturbation of cellular Ca2+ and ER/Golgi membrane network. J. Biol. Chem. 286, 42446–42458 (2011). 10.1074/jbc.m111.287383

[42]

Schiffmann, S. et al. Ceramide synthases and ceramide levels are increased in breast cancer tissue. Carcinogenesis 30, 745–752 (2009). 10.1093/carcin/bgp061

[43]

Rahmaniyan, M. et al. Identification of dihydroceramide desaturase as a direct in vitro target for fenretinide. J. Biol. Chem. 286, 24754–24764 (2011). 10.1074/jbc.m111.250779

[44]

Airola, M. V. et al. Structure of human nSMase2 reveals an interdomain allosteric activation mechanism for ceramide generation. Proc. Natl Acad. Sci. USA 114, E5549–E5558 (2017). 10.1073/pnas.1705134114

[45]

Gorelik, A., Illes, K., Heinz, L. X., Superti-Furga, G. & Nagar, B. Crystal structure of mammalian acid sphingomyelinase. Nat. Commun. 7, 12196 (2016). 10.1038/ncomms12196

[46]

Santana, P. et al. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86, 189–199 (1996). 10.1016/s0092-8674(00)80091-4

[47]

Carpinteiro, A. et al. Regulation of hematogenous tumor metastasis by acid sphingomyelinase. EMBO Mol. Med. 7, 714–734 (2015). 10.15252/emmm.201404571

[48]

Shamseddine, A. A. et al. P53-dependent upregulation of neutral sphingomyelinase-2: role in doxorubicin-induced growth arrest. Cell Death Dis. 6, e1947 (2015). 10.1038/cddis.2015.268

[49]

Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes

Katarina Trajkovic, Chieh Hsu, Salvatore Chiantia et al.

Science 2008 10.1126/science.1153124

[50]

Chen, Y. et al. Enhanced colonic tumorigenesis in alkaline sphingomyelinase (NPP7) knockout mice. Mol. Cancer Ther. 14, 259–267 (2015). 10.1158/1535-7163.mct-14-0468-t

Showing 50 of 176 references

Cited By

1,024

Simultaneous quantification of sphingolipid metabolites in human plasma using UPLC-MS/MS

Peiqi Sun, Fei Hang · 2026

Journal of Chromatography B

Targeting UGCG sensitizes AML cells to venetoclax through RAB32-mediated endoplasmic reticulum-mitochondria communication

Xiaofan Sun, Yue Li · 2026

Cell Reports

The Dual Faces of S1P: Orchestrating Immune Responses in Health and Disease

Stephanie A. Mills, David Barr · 2026

Cells

The Phospholipid Metabolic Switch in Lung Cancer: Igniting Transformation, Fortifying Survival, and Informing Therapy

Wei-Qian Bao, Tian-tian Xu · 2026

Engineering

Gut microbiota shapes cancer immunotherapy responses

Wanting Lei, Kexun Zhou · 2025

npj Biofilms and Microbiomes

The Involvement of Ceramide, Sphingosine-1-Phosphate and Ganglioside GM1 in Regulating Some Nervous System Functions

Paola Giussani, Laura Mauri · 2025

International Journal of Molecular...

Hexokinase-I directly binds to a charged membrane-buried glutamate of mitochondrial VDAC1 and VDAC2

Sebastian Bieker, Michael Timme · 2025

Communications Biology

Circulating proteins and metabolites panel for noninvasive preoperative diagnosis of epithelial ovarian cancer

Yan Jia, Li Yuan · 2025

BMC Medicine

Metabolic characterization of sphere‐derived prostate cancer stem cells reveals aberrant urea cycle in stemness maintenance

Yuanyuan Luo, Jiachuan Yu · 2024

International Journal of Cancer

Mechanisms of Abnormal Lipid Metabolism in the Pathogenesis of Disease

Linna Xu, Qingqing Yang · 2024

International Journal of Molecular...

Tumor-associated macrophage (TAM)-secreted CCL22 confers cisplatin resistance of esophageal squamous cell carcinoma (ESCC) cells via regulating the activity of diacylglycerol kinase α (DGKα)/NOX4 axis

Jie Chen, Di Zhao · 2024

Drug Resistance Updates

Plasma metabolomics of oral squamous cell carcinomas based on NMR and MS approaches provides biomarker identification and survival prediction

Giovana Mussi Polachini, Tialfi Bergamin de Castro · 2023

Scientific Reports

Lipid metabolism reprogramming in head and neck cancer

Jinfeng Liang, Lin Li · 2023

Frontiers in Oncology

Fatty Acid 2-Hydroxylase and 2-Hydroxylated Sphingolipids: Metabolism and Function in Health and Diseases

Matthias Eckhardt · 2023

International Journal of Molecular...

Development of covalent inhibitors: Principle, design, and application in cancer

Lang Zheng, Yang Li · 2023

MedComm – Oncology

VAP-A and its binding partner CERT drive biogenesis of RNA-containing extracellular vesicles at ER membrane contact sites

Bahnisikha Barman, Bong Hwan Sung · 2022

Developmental Cell

The Role of Sphingolipid Signaling in Oxidative Lung Injury and Pathogenesis of Bronchopulmonary Dysplasia

Jaya M. Thomas, Tara Sudhadevi · 2022

International Journal of Molecular...

Plasma Metabolomics for Discovery of Early Metabolic Markers of Prostate Cancer Based on Ultra-High-Performance Liquid Chromatography-High Resolution Mass Spectrometry

Xiangping Lin, Lucie Lécuyer · 2021

Cancers

Identification of Androgen Receptor Metabolic Correlome Reveals the Repression of Ceramide Kinase by Androgens

Laura Camacho, Amaia Zabala-Letona · 2021

Cancers

RAB31 marks and controls an ESCRT-independent exosome pathway

Denghui Wei, Weixiang Zhan · 2020

Cell Research

Metrics

1,024

Citations

176

References

Details

Published: Nov 17, 2017
Vol/Issue: 18(1)
Pages: 33-50
License: View

Authors

B

Besim Ogretmen

Cite This Article

Besim Ogretmen (2017). Sphingolipid metabolism in cancer signalling and therapy. Nature Reviews Cancer, 18(1), 33-50. https://doi.org/10.1038/nrc.2017.96

Sphingolipid metabolism in cancer signalling and therapy

You May Also Like